Carl Firth, Aslan Pharmaceuticals CEO
Aslan touts data for competitor to Dupixent as it seeks new partners
Aslan Pharmaceuticals said Thursday morning that its experimental drug for eczema, or atopic dermatitis, helped more patients achieve nearly clear or clear skin compared to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.